2021
DOI: 10.1248/bpb.b21-00218
|View full text |Cite
|
Sign up to set email alerts
|

Development, Characterization and Potential Applications of a Multicellular Spheroidal Human Blood–Brain Barrier Model Integrating Three Conditionally Immortalized Cell Lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 35 publications
1
11
0
Order By: Relevance
“…The hiMCS-BBB1.0 and 2.0 models were prepared for immunocytochemistry (ICC). Approximately 10–20 spheroids were pooled in a 1.5 mL Protein LoBind tube and washed with PBS(−), after which ICC was performed as described previously . The primary and secondary antibodies used are listed in Table S1.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations
“…The hiMCS-BBB1.0 and 2.0 models were prepared for immunocytochemistry (ICC). Approximately 10–20 spheroids were pooled in a 1.5 mL Protein LoBind tube and washed with PBS(−), after which ICC was performed as described previously . The primary and secondary antibodies used are listed in Table S1.…”
Section: Methodsmentioning
confidence: 99%
“…The spheroid models were developed in two different protocols. Protocol 1 is the same as described in our previous report 18 in which HASTR/ci35 and HBPC/ci37 cells were simultaneously seeded on the first day and cultured for 48 h, after which HBMEC/ci18 cells were added into the well and incubated for another 48 h (Figure 1A). The resulting model is hereafter referred to as the hiMCS-BBB1.0 model.…”
Section: ■ Materials and Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Up to six different cell types (BMECs, astrocytes, pericytes, microglia cells, oligodendrocytes, and neurons) [ 101 , 102 , 103 ]…”
Section: Figurementioning
confidence: 99%